Federally-Listed PSOs

Below is a list of PSOs that are currently listed by AHRQ. A health care provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO.

Use the categories on the left to filter the list of PSOs or search a PSO name.

Note: AHRQ updates the PSO information contained within the directories weekly, as needed; changes are made when there are newly listed PSOs and/or when existing information requires revision. Changes that would otherwise be effective on a weekend day or holiday will be effective on the next business day. Information contained in the directories is based on attestations that the PSOs provide. To update PSO contact information, please use the Change of Listing Information form; to update profile information, please go to the PSO PPC Web site.

There are 83 total PSOs listed by AHRQ.

Academic Medical Center (AMC) PSO - P0103
Component of Parent Org(s):
  • Risk Management Foundation of the Harvard Medical Institutions, Inc.
Effective Date and Time of Initial Listing: December 22, 2010 12:01 AM ET
Street Address: 1325 Boylston Street, Boston, Massachusetts 02215
PSO Phone Number: (617) 450-5586
Point of Contact: Katherine Zigmont
Point of Contact Phone: 617-450-6804
Point of Contact Email: kzigmont@rmf.harvard.edu (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 12/22/2018 through 12/21/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
DaVita Institute for Patient Safety, Inc. - P0174
    PSO Alternate Legal Name: DaVita Patient Safety Organization
Component of Parent Org(s):
  • DaVita HealthCare Partners Inc.
  • DaVita Inc.
Effective Date and Time of Initial Listing: January 21, 2016 12:01 AM ET
Street Address: 2000 16th St. #1352, Denver, Colorado 80202
PSO Phone Number: (303) 876-6672
Point of Contact: Johanna Elliott
Point of Contact Phone: 717-884-1260
Point of Contact Email: Johanna.elliott@davitapso.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 01/21/2020 through 01/20/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: Yes
Emergency Medical Error Reduction Group - P0133
Component of Parent Org(s):
  • Center for Leadership, Innovation and Research in EMS
Effective Date and Time of Initial Listing: November 28, 2012 12:01 AM ET
Street Address: 2800 North 7th Street, St. Cloud, Minnesota 56303
PSO Phone Number: 919-448-8618
Point of Contact: Nathaniel Metz
Point of Contact Phone: 765-237-4129
Point of Contact Email: metz@emerg.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/28/2018 through 11/27/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Florida Academic Healthcare Patient Safety Organization - P0148
Component of Parent Org(s):
  • Florida Atlantic University Self-Insurance Program
  • Florida Board of Governors
  • Florida International University Self-Insurance Program
  • Florida State University Self-Insurance Program
  • University of Central Florida Self-Insurance Program
  • University of Florida Self-Insurance Program
  • University of South Florida Self-Insurance Program
Effective Date and Time of Initial Listing: April 22, 2014 12:01 AM ET
Street Address: 201 SE 2nd Avenue, Suite 209, Gainesville, Florida 32601
PSO Phone Number: (352) 273-7006
Point of Contact: Kristin L. Belyew
Point of Contact Phone: (352) 273-7006
Point of Contact Email: belyewk@ufl.edu (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 04/22/2020 through 04/21/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Health Catalyst Patient Safety Organization (HCPSO) - P0201
Component of Parent Org(s):
  • Health Catalyst, Inc
Effective Date and Time of Initial Listing: July 24, 2018 12:01 AM ET
Street Address: 3165 E Millrock Dr. Suite 400, Salt Lake City, Utah 84121
PSO Phone Number: (801) 708-6800
Point of Contact: Robert Michael Barton PharmD
Point of Contact Phone: 801-708-6800
Point of Contact Email: michael.barton@healthcatalyst.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 07/24/2018 through 07/23/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Louisiana Alliance for Patient Safety PSO - P0186
Component of Parent Org(s):
  • Louisiana Hospital Association
Effective Date and Time of Initial Listing: November 8, 2016 12:01 AM ET
Street Address: 9521 Brookline Ave, Baton Rouge, Louisiana 70809
PSO Phone Number: 225-928-0026
Point of Contact: Floyd J. Roberts Jr., MD, FACP, FCCP
Point of Contact Phone: 225-928-0026, ext. 206
Point of Contact Email: froberts@lhaonline.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/08/2020 through 11/07/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Safety Culture Patient Safety Organization - P0175
Component of Parent Org(s):
  • Walmart Stores, Inc
Effective Date and Time of Initial Listing: December 14, 2015 12:01 AM ET
Street Address: 702 SW 8th Street Mailstop 430, Bentonville, Arkansas 72716
PSO Phone Number: 479-204-9188
Point of Contact: Colleen Elizabeth Jones
Point of Contact Phone: 479-204-5577
Point of Contact Email: colleen.jones@walmart.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 12/14/2019 through 12/13/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Strategic Radiology Patient Safety Organization LLC - P0144
Component of Parent Org(s):
  • Strategic Radiology LLC
Effective Date and Time of Initial Listing: June 19, 2013 12:01 AM ET
Street Address: 5827 East Larkspur Dr., Scottsdale, Arizona 85254
PSO Phone Number: (810) 210-9885
Point of Contact: Lisa A. Mead MS, CPHQ
Point of Contact Phone: (480) 794-0483
Point of Contact Email: lmead@strategicradiology.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 06/19/2019 through 06/18/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No